ABSTRACT
Systemic complications of intravesicular BCG for bladder carcinoma are uncommon, and include fever, pneumonia, hepatitis, arthralgias, or skin rash. Local complications of BCG therapy for bladder cancer include cystitis, prostatitis, epididymo-orchitis, granulomatous lymphadenitis, or ureteral obstruction. We believe this is the first case of Mycobacterium bovis vertebral osteomyelitis and psoas abscess complicating intravesicular BCG therapy for bladder carcinoma.
Subject(s)
BCG Vaccine/adverse effects , Lumbar Vertebrae , Osteomyelitis/microbiology , Psoas Abscess/microbiology , Tuberculosis, Spinal/microbiology , Administration, Intravesical , Aged , BCG Vaccine/therapeutic use , Carcinoma, Transitional Cell/therapy , Humans , Male , Osteomyelitis/diagnosis , Tuberculosis, Spinal/diagnosis , Urinary Bladder Neoplasms/therapySubject(s)
Leydig Cell Tumor/pathology , Testicular Neoplasms/pathology , Black or African American , Aged , Humans , MaleABSTRACT
Testicular tumors in infants and children are rare and most of them are malignant. Embryonal carcinoma is the most common childhood neoplasm, while seminoma is predominantly found in adults. Hemangioma of the testis is an extremely rare tumor, only 2 cases having been reported in infants.
